Optimizing Drug Dosing in the ICU
Patients admitted to the intensive care unit (ICU) may exhibit multiple organ dysfunctions and usually require treatment with a wide range of drugs such as sedatives, analgesics, neuromuscular blockers, and antimicrobials . Recommendations for the dosing regimens in ICU patients are often extrapolated from clinical trials in healthy volunteers or non-ICU patients. This extrapolation assumes similar drug behavior (pharmacokinetics and pharmacodynamics) among ICU and other patients or healthy volunteers. However, it is well described that many drugs used in critically ill patients may have alterations of the pharmacokinetic and pharmacodynamic properties due to pathophysiological changes or drug interactions [1, 2, 3, 4]. These changes may occur even within a single patient at varying stages of their illness and, therefore, critically ill patients offer unique challenges in drug dosing.
KeywordsIntensive Care Unit Intensive Care Unit Patient Continuous Renal Replacement Therapy Hepatic Blood Flow Bayesian Forecast
Unable to display preview. Download preview PDF.
- 11.Herfindaland ET, Gourley DR (2000) Textbook of Therapeutics: Drug and Disease Management. Lippincott Williams and Wilkins, PhiladelphiaGoogle Scholar
- 21.Buijk SL, Gyssens IC, Mouton JW, Van Vliet A, Verbrugh HA, Bruining HA (2002) Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections. J Antimicrob Chemother 49: 121–128CrossRefPubMedGoogle Scholar
- 40.Denaroand CP, Ravenscroft PJ (1989) Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patients. Br J Clin Pharmacol 28: 37–44Google Scholar
- 42.U.S. Department of Health and Human Services, FDA, CDER, CBER (1999) Guidance for industry: population pharmacokinetics. Available at: http://www.fda.gov/cber/gdlns/popharm. pdf Accessed Nov 2008Google Scholar